Viewing Study NCT00249756



Ignite Creation Date: 2024-05-05 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00249756
Status: COMPLETED
Last Update Posted: 2013-09-02
First Post: 2005-11-03

Brief Title: Re-Entry MTC for Offenders With MICA Disorders
Sponsor: National Development and Research Institutes Inc
Organization: National Development and Research Institutes Inc

Study Overview

Official Title: Re-Entry MTC for Offenders With MICA Disorders
Status: COMPLETED
Status Verified Date: 2013-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to examine the transition of offenders with both mental illness and chemical abuse MICA disorders from prison to the community where continued treatment is generally considered necessary to sustain gains made by prison treatment and to achieve successful outcomes The project will determine the effectiveness of a modified therapeutic community Re-Entry MTC approach as compared to the case management and parole supervision currently provided The study will also assess the relative impact on treatment outcomes of the type of treatment received while in prison and of the progress achieved in re-entry treatment
Detailed Description: Offenders having both mental illness and chemical abuse MICA disorders are a population of interest in part because their special needs place exceptional demands on criminal justice and treatment systems as well as on individuals and families This study examines the crucial point of transition from prison to the community where continued treatment for offenders is generally considered necessary to sustain gains made by prison treatment efforts and to achieve successful outcomes The project has two specific aims Aim 1 is to test the effectiveness of Re entry MTC treatment relative to a control condition and Aim 2 is to assess the relative impact on treatment outcomes of the type of treatment received while in prison and of the progress achieved in re-entry treatment

On their release from prison male offenders with MICA disorders who elect to participate in this study N 332 will be placed in either the experimental condition E Re-entry Modified Therapeutic Community Re-entry MTC or the control condition C Parole Supervision and Case Management currently provided using a randomized block assignment procedure The research employs a prospective longitudinal repeated measures assessment with five data collection points baseline Time 1 or T1 corresponding to entry into the Community Corrections facility and at 3 T2 6 T3 12 T4 and 18 T5 months post-baseline The major study hypothesis is that the E condition compared to the C condition will produce significantly greater improvement in the presenting problems of the study participants as measured by substance use mental health symptoms and criminal activities

This project will advance scientific knowledge through a controlled study of the effectiveness of the MTC model with demonstrated success in community settings as a re-entry strategy for offenders with MICA disorders thereby expanding the range of treatment models available to such clients in the community In addition the study will examine the degree to which prior prison treatment moderates the effectiveness of the Re-entry MTC or the extent to which positive outcomes are independent of the type of treatment received during the prior incarceration This distinction will inform program planning by establishing the value of MTC treatment in prison plus MTC during re-entry versus MTC re-entry treatment alone Finally the study tests a specific hypothesis about the degree to which the effectiveness of Re-entry MTC treatment is mediated by client progress during reentry which will increase our understanding of the relationship between progress in treatment and post-treatment outcomes for offenders with MICA disorders

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
R01-19982-1 US NIH GrantContract None httpsreporternihgovquickSearchR01DA019982
R01DA019982 NIH None None